281 related articles for article (PubMed ID: 24200688)
1. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.
Xanthakis V; Larson MG; Wollert KC; Aragam J; Cheng S; Ho J; Coglianese E; Levy D; Colucci WS; Michael Felker G; Benjamin EJ; Januzzi JL; Wang TJ; Vasan RS
J Am Heart Assoc; 2013 Nov; 2(6):e000399. PubMed ID: 24200688
[TBL] [Abstract][Full Text] [Related]
2. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
[TBL] [Abstract][Full Text] [Related]
3. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
[TBL] [Abstract][Full Text] [Related]
4. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis.
Li J; Ning B; Wang Y; Li B; Qian J; Ren H; Zhang J; Hu X
Medicine (Baltimore); 2019 Mar; 98(13):e15070. PubMed ID: 30921240
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
[TBL] [Abstract][Full Text] [Related]
7. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
[TBL] [Abstract][Full Text] [Related]
8. Association of change in 5-year N-terminal fragment of the prohormone brain-type natriuretic peptide with left ventricular structure and function in stable coronary disease.
Psotka MA; Schiller NB; Whooley MA; Mishra RK
J Cardiovasc Med (Hagerstown); 2018 Feb; 19(2):67-72. PubMed ID: 29251695
[TBL] [Abstract][Full Text] [Related]
9. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
[TBL] [Abstract][Full Text] [Related]
10. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction.
Goetze JP; Mogelvang R; Maage L; Scharling H; Schnohr P; Sogaard P; Rehfeld JF; Jensen JS
Eur Heart J; 2006 Dec; 27(24):3004-10. PubMed ID: 17118955
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.
Hanatani S; Izumiya Y; Takashio S; Kojima S; Yamamuro M; Araki S; Rokutanda T; Tsujita K; Yamamoto E; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
Heart Vessels; 2014 Mar; 29(2):231-7. PubMed ID: 23525862
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial.
Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
15. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
16. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy.
Lukowicz TV; Fischer M; Hense HW; Döring A; Stritzke J; Riegger G; Schunkert H; Luchner A;
Eur J Heart Fail; 2005 Jun; 7(4):525-31. PubMed ID: 15921790
[TBL] [Abstract][Full Text] [Related]
17. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
[TBL] [Abstract][Full Text] [Related]
18. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
19. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease.
Reinier K; Dervan C; Singh T; Uy-Evanado A; Lai S; Gunson K; Jui J; Chugh SS
Heart Rhythm; 2011 Aug; 8(8):1177-82. PubMed ID: 21376836
[TBL] [Abstract][Full Text] [Related]
20. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography.
Ng LL; Loke I; Davies JE; Khunti K; Stone M; Abrams KR; Chin DT; Squire IB
Eur J Heart Fail; 2003 Dec; 5(6):775-82. PubMed ID: 14675856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
